From premorbid adjustment dimensions to clinical outcomes: Exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypes.

Saved in:
Bibliographic Details
Title: From premorbid adjustment dimensions to clinical outcomes: Exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypes.
Authors: Pérez-Ramos A; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Neuropsychopharmacology and Psychobiology Research Group, Department of Neuroscience, University of Cadiz, Cadiz, Spain., Gonzalez-Segura À; Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Julià L; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., García-Rizo C; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain., Sánchez-Torres A; Department of Health Sciences, Universidad Pública de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Spain., Cavone V; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain., Zorrilla I; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; BIOARABA, Department of Psychiatry, Hospital Universitario de Alava, UPV/EHU, Vitoria, Spain., Mané A; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Grup MERITT, Institut de Recerca Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, Barcelona, Spain., Rodriguez-Jimenez R; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Universidad Complutense de Madrid (UCM), Spain; Department of Psychiatry, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Roldan A; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Psychiatry Department, Hospital de la Santa Creu i Sant Pau, IIB SANT PAU, Barcelona, Spain., Pomarol-Clotet E; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain., Ibañez A; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Department of Psychiatry, Hospital Universitario Ramon y Cajal, Universidad de Alcala, Instituto Ramon y Cajal de Investigacion Sanitaria (IRYCIS), Madrid, Spain., Usall J; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Etiopatogènia i tractament dels trastorns mentals greus (MERITT), Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain; Parc Sanitari Sant Joan de Déu, Doctor Antoni Pujadas, Sant Boi de Llobregat, Spain., Lobo A; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Department of Medicine and Psychiatry, Universidad de Zaragoza, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain., Bioque M; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain., Bernardo M; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Emeritus Consultant, Barcelona Clínic Schizophrenia Unit, Hospital Clínic of Barcelona, Barcelona, Spain., Cuesta MJ; Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Spain; Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain., Parellada M; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain., González-Pinto A; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; BIOARABA, Department of Psychiatry, Hospital Universitario de Alava, UPV/EHU, Vitoria, Spain., Berrocoso E; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Neuropsychopharmacology and Psychobiology Research Group, Department of Neuroscience, University of Cadiz, Cadiz, Spain; Biomedical Research and Innovation Institute of Cadiz (INiBICA), Research Unit, Puerta del Mar University Hospital, Cádiz, Spain., Amoretti S; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Mezquida G; Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Serra-Hunter Lecturer Fellow, Department of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain. Electronic address: mezquida@recerca.clinic.cat.
Corporate Authors: 2EPs Working Group, Members of 2EPs Working Group
Source: Spanish journal of psychiatry and mental health [Span J Psychiatry Ment Health] 2026 Apr-Jun; Vol. 19 (2), pp. 99-110. Date of Electronic Publication: 2025 Nov 14.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Spain S.L Country of Publication: Spain NLM ID: 9918697477806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2950-2853 (Electronic) Linking ISSN: 29502853 NLM ISO Abbreviation: Span J Psychiatry Ment Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2950-2853
DOI:10.1016/j.sjpmh.2025.08.002